Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07233148 · ClinicalTrials.gov registry record
Healing ALS Registry Observational Study (HAROS)
A clinical trial of Amyotrophic Lateral Sclerosis (ALS) and Primary Lateral Sclerosis (PLS), sponsored by Healing Advocates Registry and Ministry.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT07233148: Recruiting study of Amyotrophic Lateral Sclerosis (ALS) and Primary Lateral Sclerosis (PLS), sponsored by Healing Advocates Registry and Ministry.
NCT07233148 is a study of Amyotrophic Lateral Sclerosis (ALS) and Primary Lateral Sclerosis (PLS) that is actively recruiting participants, run by Healing Advocates Registry and Ministry. The registered enrollment target is 1,000 participants, above the 247-participant average among 18 other Amyotrophic Lateral Sclerosis (ALS) trials with a reported enrollment target (305% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07233148, a study of Amyotrophic Lateral Sclerosis (ALS) and Primary Lateral Sclerosis (PLS), is actively recruiting participants, sponsored by Healing Advocates Registry and Ministry.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, observational, online study of people diagnosed with ALS, MND or PLS referred to as HAROS (Healing ALS Registry Observational Study). Participants will enter information into an online ALS registry once per month, including their ALSFRS-R data, certain other symptoms, dietary intake, supplements, medications and other therapies, both conventional and integrative. Participants will also enter the hours spent on optional self-study and free online education. The investigators will assess the effectiveness of various therapies and education by measuring physical outcomes.
Primary Outcome
ALS Functional Ratings Scale is a set of 12 questions, with a maximum of 4 points per question and measures physical functionality. Outcomes are measured at a point in time and range from 0 for no functionality to 48 for full functionality in all areas measured. The higher the score the better the outcome.
Conditions Studied
Interventions
- OTHER Education about treatment options
- DIETARY_SUPPLEMENT Dietary Supplements: Vitamins, Minerals, Herbs, etc.
- BEHAVIORAL Meditation, Prayer, Talk Therapy, Affirmations, Journaling, etc.
- OTHER Diet, various diets will be observed
- OTHER Exercise, physical therapy, occupational therapy, speech therapy, sauna, EMS, massage and other therapies
Study Locations (1)
Utah
- Virtual - Park City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2026-01-26 |
| Est. Completion | 2036-03-31 |
What NCT07233148 shows while recruiting
NCT07233148 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 247-participant average among 18 other Amyotrophic Lateral Sclerosis (ALS) trials with a reported enrollment target (305% higher).
The record links to 3 conditions, with Amyotrophic Lateral Sclerosis (ALS) appearing as the primary indexed condition, and to 5 interventions - of which Education about treatment options is the first listed.
NCT07233148 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT07233148 about?
NCT07233148 is a clinical study titled "Healing ALS Registry Observational Study (HAROS)". This is a prospective, observational, online study of people diagnosed with ALS, MND or PLS referred to as HAROS (Healing ALS Registry Observational Study). Participants will enter information into an online ALS registry once per month, including their ALSFRS-R data, certain other symptoms, dietary ...
What is the current status of trial NCT07233148?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2026-01-26. Estimated completion is 2036-03-31.
What conditions does trial NCT07233148 study?
This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis (ALS), Primary Lateral Sclerosis (PLS), Motor Neuron Disease (MND).
What interventions are being tested in trial NCT07233148?
The interventions under investigation include: Education about treatment options (OTHER), Dietary Supplements: Vitamins, Minerals, Herbs, etc. (DIETARY_SUPPLEMENT), Meditation, Prayer, Talk Therapy, Affirmations, Journaling, etc. (BEHAVIORAL), Diet, various diets will be observed (OTHER), Exercise, physical therapy, occupational therapy, speech therapy, sauna, EMS, massage and other therapies (OTHER).
Who is sponsoring clinical trial NCT07233148?
This trial is sponsored by Healing Advocates Registry and Ministry, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07233148 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyotrophic Lateral Sclerosis (ALS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07233148's enrollment target sits among peer trials
1,000 2nd of 18 higher than 16 of 18 other Amyotrophic Lateral Sclerosis (ALS) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amyotrophic Lateral Sclerosis (ALS) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.
RECRUITING · NA
-
Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial
RECRUITING · Phase 2
-
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
RECRUITING · Phase 1
-
Study of COYA 302 for the Treatment of ALS
RECRUITING · Phase 2
-
PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
RECRUITING · Phase 2
-
Retinal Imaging in Neurodegenerative Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI